![]()
|
Report Date : |
15.07.2008 |
IDENTIFICATION
DETAILS
|
Name : |
SARL INDUSTRIES MEDICO CHIRURGICALES |
|
|
|
|
Registered Office : |
Zone Industrielle Rouiba voie A, Alger 16310 |
|
|
|
|
Country : |
Algeria |
|
|
|
|
Date of Incorporation : |
1989 |
|
|
|
|
Com. Reg. No.: |
99B0007801 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacturer Basic
Pharmaceutical Products Manufacturer Other Chemical
Products |
RATING & COMMENTS
|
MIRA’s Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
SARL
INDUSTRIES MEDICO CHIRURGICALES
Registration
Number: 99B0007801
Registration
Date: 1989
Legal
Form: PRIVATE
LIMITED CO
Latest
Financials: N/A
Nominal
Capital: 670,000,000
Algerian Dinars
Issued
Capital: N/A
Turnover: N/A
Net
Profit: N/A
Net
Worth: N/A
Company
Name: SARL
IMC
Country: AG
Street
Name: INDUSTRIES
MEDICO CHIRUCICALES,ZONE IND VOIE A
City
Code: ALGER
Post
Code: ROUIBA,WILAY
Phone
Number: 00213
21811905/06
Fax Number: 00213
21813273
Company Name: SARL
INDUSTRIES MEDICO CHIRURGICALES
Company acronym: IMC
Headquarter Address: Zone
Industrielle Rouiba voie A,
Rouiba,
alger 16310,
Algeria
Telephone: +21321
811905
+21321 811906
+21321 812714
Fax: +21321
812714
+21321 813273
+21321 813274
E‑Mail: nadir.abderrahim@hec.ca
/ export@imc‑dz.com
Web Site: www.imc‑dz.com
Company was
originally started on 1989
Current Legal Form: PRIVATE
LIMITED CO
Registration Address: Zone
Industrielle Rouiba voie A,
alger 16310
Registration Number: 99B0007801
Registration Date: 1989
Year/Date Company Established: 1989
Registration Town: Alger
Tax Registration Number: 099035030036242
Currency: Algerian Dinars
Nominal Capital: 670,000,000
Paid Up Capital: 670,000,000
Shareholders:
Name/Address
Shares Held % of
Voting/Non‑Voting capital
Mohamed Zineddine Bachtarzi
(Principal Shareholder),
Algeria
Principals
Name: Dr Mohamed
Zineddine Bachtarzi
Position within the company: General manager
Country of Birth: Algeria
Nationality: Algerian
Can
fluently speak: Aabic/french/english
Name: Mr
Nadir Abderrahim
Position
within the company: Managing
director
Country
of Birth: Algeria
Nationality: Algerian
Can
fluently speak: Aabic/french/english
Name: Mr
Fares Bachtarzi
Position
within the company: Commercial
Director
Country
of Birth: Algeria
Nationality: Algerian
Can
fluently speak: French/english
Name: Mr
Salim Grine
Position
within the company: Export
Director
Country
of Birth: Algeria
Nationality: Algerian
Can
fluently speak: French
NACE Codes: 2441 Mfg
basic pharmaceutical products
2466 Mfg other chemical products nec
The company is involved in the
manufacture of consumable medical,consumable medico‑surgical of Single
use,massive aqueous solutions and concentrate Acid for hemodialysis, the
subject is also involved in the assemblies of equipments and materials related
to the dialysis field.
These goods are made from imported and
purchased raw materials and products then sold to the local and foreign clients
in a wholesale basis.
Local Reporters consider the
investigated company to be LARGE in their field of concern.
Operations
HQ Premises Operates
from: Owned Office , Factory,
Warehouse, Workshop
Location: Industrial
Area, Main Road
Import % and type of product: 70% Raw Materials
Imports From: Italy,
Germany, France, Spain
Importing Terms: 120 days
credit, letters of credit
Additional Information: The other
payment method is bank transfert.
Export % and type of product: 20%
Exports To: Africa,
Middle East
Exporting Terms: bank
transfer
Local Purchases
Purchasing Terms: 60 days
bank transfer
Trading & Selling
Territory: 80%
Nationally, 20% International
Terms of Sales: bank
transfer
Additional Information: The subject buys
30% raw materials locally.
Type of Customer: Hospitals
and clinics
Affiliates
BIOLYSE
Zone Industrielle Rouiba, Voie
A,16310,
Rouiba,
Algeria
Operates
as: A manufacture of massive aqueous solutions (glucosed and salted) and
concentrates for hemodialysis.
Related
through: a common shareholder
RENADIAL
Cite
Cadat Lot N°149 16013,
ROUIBA,
Algeria
Operates
as: Private clinics and Centers Of
specialises Care.
Related
through: a common shareholder
BANQUE
NATIONAL D'ALGERIE SPA,
Branch:
Agence Rouiba
Premier
Novembre 1954 Rouiba,
Alger
16013,
Algeria
Currency:
Algerian Dinars
BNP
PARIBAS,
Branch:
Rouiba
Rouiba
16000,
Algeria
CITY
BANK,
Branch:
ALGER
ALGER
16000,
Algeria
Financial information is not
available/applicable
Subject's payments reported to
be: NO COMPLAINTS
Name/Title: Salim
Grine Export Director
Comment: Subject
has confirmed the general details provided in the report but has declined to
provide any Financial Data.
Reporter
Comment: In
the interview conducted with Mr.Salim Grine,he confirmed details shown in this
report and declined to provide full financials,bank account number and the
shareholders details stating the grounds of the company’s confidentiality.
As per Algerian Commercial law
companies, except the quoted public limited ones, are not required to file
their financials and are under no obligation to provide such details to third
parties, representatives and or correspondents representing international and
or local clientele.
Please be informed that the subject is created in 1989 but
started producing in 1991.
Local
Reputation: The
company being investigated is considered by local reporters to be a Fair /
Normal Trade Risk.
General Conclusion: Local informants
consider granting of credit to be a fair trade risk.
Age of Business: The
company is long established in the local market.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.43.17 |
|
UK Pound |
1 |
Rs.86.46 |
|
Euro |
1 |
Rs.68.68 |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)